190 related articles for article (PubMed ID: 24607780)
1. The vascular endothelin system in obesity and type 2 diabetes: pathophysiology and therapeutic implications.
Campia U; Tesauro M; Di Daniele N; Cardillo C
Life Sci; 2014 Nov; 118(2):149-55. PubMed ID: 24607780
[TBL] [Abstract][Full Text] [Related]
2. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.
Mather KJ; Mirzamohammadi B; Lteif A; Steinberg HO; Baron AD
Diabetes; 2002 Dec; 51(12):3517-23. PubMed ID: 12453909
[TBL] [Abstract][Full Text] [Related]
3. Intricacies of the endothelin system in human obesity: role in the development of complications and potential as a therapeutic target.
Schinzari F; Cardillo C
Can J Physiol Pharmacol; 2020 Sep; 98(9):563-569. PubMed ID: 32808824
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study.
Walther G; Obert P; Dutheil F; Chapier R; Lesourd B; Naughton G; Courteix D; Vinet A
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):1022-9. PubMed ID: 25657309
[TBL] [Abstract][Full Text] [Related]
5. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
Schinzari F; Tesauro M; Cardillo C
J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal relationships between insulin resistance and endothelial dysfunction: insights from therapeutic interventions.
Quon MJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):305-12. PubMed ID: 16859113
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction, obesity and insulin resistance.
Prieto D; Contreras C; Sánchez A
Curr Vasc Pharmacol; 2014 May; 12(3):412-26. PubMed ID: 24846231
[TBL] [Abstract][Full Text] [Related]
8. Linking the beneficial effects of current therapeutic approaches in diabetes to the vascular endothelin system.
Matsumoto T; Lopes RA; Taguchi K; Kobayashi T; Tostes RC
Life Sci; 2014 Nov; 118(2):129-35. PubMed ID: 24418002
[TBL] [Abstract][Full Text] [Related]
9. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
10. Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: an overview.
Toda N; Okamura T
J Clin Pharmacol; 2013 Dec; 53(12):1228-39. PubMed ID: 24030923
[TBL] [Abstract][Full Text] [Related]
11. Increased endothelin-1-mediated vasoconstrictor tone in human obesity: effects of gut hormones.
Schinzari F; Tesauro M; Cardillo C
Physiol Res; 2018 Jun; 67(Suppl 1):S69-S81. PubMed ID: 29947529
[TBL] [Abstract][Full Text] [Related]
12. Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats.
Eringa EC; Stehouwer CD; Roos MH; Westerhof N; Sipkema P
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1134-9. PubMed ID: 17623751
[TBL] [Abstract][Full Text] [Related]
13. Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice.
Amiri F; Ko EA; Javeshghani D; Reudelhuber TL; Schiffrin EL
J Hypertens; 2010 Jun; 28(6):1243-51. PubMed ID: 20308920
[TBL] [Abstract][Full Text] [Related]
14. Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond.
Stepp DW
Clin Exp Pharmacol Physiol; 2006; 33(5-6):407-14. PubMed ID: 16700872
[TBL] [Abstract][Full Text] [Related]
15. Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome.
Schinzari F; Tesauro M; Rovella V; Galli A; Mores N; Porzio O; Lauro D; Cardillo C
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E947-52. PubMed ID: 20923961
[TBL] [Abstract][Full Text] [Related]
16. Altered foetoplacental vascular endothelial signalling to insulin in diabesity.
Pardo F; Subiabre M; Fuentes G; Toledo F; Silva L; Villalobos-Labra R; Sobrevia L
Mol Aspects Med; 2019 Apr; 66():40-48. PubMed ID: 30849412
[TBL] [Abstract][Full Text] [Related]
17. Vascular insulin-like growth factor-I resistance and diet-induced obesity.
Imrie H; Abbas A; Viswambharan H; Rajwani A; Cubbon RM; Gage M; Kahn M; Ezzat VA; Duncan ER; Grant PJ; Ajjan R; Wheatcroft SB; Kearney MT
Endocrinology; 2009 Oct; 150(10):4575-82. PubMed ID: 19608653
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
Rask-Madsen C; King GL
Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity.
Bakker W; Eringa EC; Sipkema P; van Hinsbergh VW
Cell Tissue Res; 2009 Jan; 335(1):165-89. PubMed ID: 18941783
[TBL] [Abstract][Full Text] [Related]
20. Dysfunction of human subcutaneous fat arterioles in obesity alone or obesity associated with Type 2 diabetes.
Georgescu A; Popov D; Constantin A; Nemecz M; Alexandru N; Cochior D; Tudor A
Clin Sci (Lond); 2011 May; 120(10):463-72. PubMed ID: 20979575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
